Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...
Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...
The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug ...
With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...
FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking ...
Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...
The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...
Affiliate content. See how LeanBliss and SuperThin stack up against each other when it comes to weight loss support.
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.